Upstream Bio (UPB) Receivables - Other (2023 - 2026)

Upstream Bio's Receivables - Other history runs 4 years deep, the most recent figure standing at $1.6 million for Q1 2026.

• In Q1 2026, Receivables - Other rose 34.22% year-over-year to $1.6 million; the TTM figure through Mar 2026 stood at $1.6 million (up 34.22% YoY), while the FY2025 annual figure was $1.7 million, up 191.53% from the prior year.
• Receivables - Other for Q1 2026 stood at $1.6 million, down from $1.7 million in the prior quarter.
• The five-year high for Receivables - Other was $1.7 million in Q2 2025, with the low at $138000.0 in Q4 2023.
• The 4-year median for Receivables - Other is $1.4 million (2025), against an average of $1.1 million.
• The sharpest annual moves came in 2024 and 2026: Receivables - Other soared 310.87% in 2024, then jumped 34.22% in 2026.
• Upstream Bio's Receivables - Other stood at $138000.0 in 2023, then jumped by 310.87% to $567000.0 in 2024, then soared by 191.53% to $1.7 million in 2025, then fell by 4.84% to $1.6 million in 2026.
• Business Quant data shows UPB's Receivables - Other at $1.6 million in Q1 2026, $1.7 million in Q4 2025, and $1.6 million in Q3 2025.